Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
69.09
+2.48 (3.72%)
Feb 23, 2026, 12:50 PM EST - Market open
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| 182.95M | 17.45M | 25.82M | 57.03M | - | | |
| 948.62% | -32.42% | -54.73% | - | - | | |
| 182.95M | 17.45M | 25.82M | 57.03M | - | | |
| 948.62% | -32.42% | -54.73% | - | - | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| 182.95M | 17.45M | 25.82M | 57.03M | - | | |
| 948.62% | -32.42% | -54.73% | - | - | | |
| 182.95M | 17.45M | 25.82M | 57.03M | - | | |
| 948.62% | -32.42% | -54.73% | - | - | | |
Source: S&P Global Market Intelligence.
